Ion Beam Applications
13.44
26-November-24 10:08:02
15 minutes delayed
Stocks
-0.46
-3.31%
Today's range
13.26 - 13.56
ISIN
BE0003766806
Source
Cboe
-
IBA and ScandiDos form strategic alliance to increase access to safe radiotherapy
30 Aug 2022 12:00:00 By Nasdaq GlobeNewswire
-
26 Aug 2022 01:00:00 By Nasdaq GlobeNewswire
-
02 Aug 2022 01:00:00 By Nasdaq GlobeNewswire
-
30 Jun 2022 01:00:00 By Nasdaq GlobeNewswire
-
01 Jun 2022 01:00:00 By Nasdaq GlobeNewswire
-
IBA Business Update – First Quarter 2022
19 May 2022 01:00:00 By Nasdaq GlobeNewswire
-
IBA continues to shape the future of proton therapy at ESTRO 2022 Annual Congress
06 May 2022 01:00:00 By Nasdaq GlobeNewswire
-
IBA Receives Order from CGNNT for a Proteus®PLUS System to be Installed in Yangzhou, China
05 May 2022 01:00:00 By Nasdaq GlobeNewswire
-
IBA Strengthens its Dosimetry Portfolio with Acquisition of Modus Medical Devices Inc.
03 May 2022 01:00:00 By Nasdaq GlobeNewswire
-
IBA – Transparency Notification
22 Apr 2022 00:55:00 By Nasdaq GlobeNewswire
-
IBA and UMC Groningen engage in FLASH irradiation research collaboration for breast cancer
05 Apr 2022 01:00:00 By Nasdaq GlobeNewswire
-
IBA Reports Full Year 2021 Results
24 Mar 2022 02:00:00 By Nasdaq GlobeNewswire
-
IBA and Tractebel announce partnership to support proton therapy construction projects
15 Mar 2022 10:00:00 By Nasdaq GlobeNewswire
-
IBA – ACQUISITION OF OWN SHARES COMPLETION OF THE SHARE BUYBACK PROGRAM
10 Mar 2022 13:25:00 By Nasdaq GlobeNewswire
-
IBA – Transparency Notification
08 Mar 2022 13:20:00 By Nasdaq GlobeNewswire
-
Iba – Acquisition of Own Shares
07 Mar 2022 12:32:00 By Nasdaq GlobeNewswire
-
Iba – Acquisition of Own Shares
28 Feb 2022 12:27:00 By Nasdaq GlobeNewswire
-
IBA – ACQUISITION OF OWN SHARES
21 Feb 2022 13:11:00 By Nasdaq GlobeNewswire
-
IBA – ACQUISITION OF OWN SHARES
14 Feb 2022 12:33:00 By Nasdaq GlobeNewswire
-
IBA and SOGAZ Insurance Group sign contract for Proteus®ONE proton therapy solution in Russia
14 Feb 2022 01:00:00 By Nasdaq GlobeNewswire